Regulatory T cells (Tregs), characterized as a CD4+CD25+FOXP3+ subset of T cells, are vital to the induction of immune tolerance and the maintenance of immune homeostasis. While target genes of Treg master regulator FOXP3 have been identified, the upstream regulatory machinery of FOXP3 still remains largely unknown. Here we dynamically model causal relationships among genes from available time-series genome-scale datasets, to predict direct or indirect regulatory genes of FOXP3 in human primary Tregs. From the whole genome, we selected five top ranked candidates for further experimental validation. Following knockdown, three out of the five candidates indeed showed significant effects on the mRNA expression of FOXP3. Further experiments showed that one out of these three predicted candidates, namely nuclear receptor binding factor 2 (NRBF2), also affected FOXP3 protein expression. These results open new doors to identify potential new mechanisms of immune related diseases. * These authors contributed equally to this work.
Regulatory T cells (Tregs) are key players of the immune system, which in turn plays a crucial role in a wide range of diseases. It is well established that the transcription factor FOXP3 is a master regulator of Tregs. However, genes regulating FOXP3 are still largely unknown and identifying them may be vital for developing new immunotherapeutics. This paper computationally screens the whole genome for potential regulators of FOXP3, and then experimentally validates them. Overall, the paper illustrates how the combination of genome-wide time-series data with dynamical modelling can identify a small set of relevant causal interactions.
Tregs perform immunosuppression of self-reactive lymphocytes to induce immunological self-tolerance and maintain homeostasis [Josefowicz et al., 2012; Kenneth et al., 2012; Li et al., 2015] . Tregs are involved in different types of diseases, such as autoimmune diseases [Dejaco et al., 2006; Fehérvari and Sakaguchi, 2004; Sakaguchi et al., 2006] , cancer [Franchina et al., 2018; Shang et al., 2015; Tanaka and Sakaguchi, 2017] , infectious diseases [Joosten and Ottenhoff, 2008; Stephen-Victor et al., 2017] , neurodegenerative diseases [Baruch et al., 2015; He and Balling, 2013] and others [Cools et al., 2007] .
The transcription factor FOXP3 has been shown to play a decisive role for the development and function of Tregs [Ziegler, 2006] . This gene is expressed specifically in CD4+CD25+ Tregs [Hori et al., 2003; Rudensky, 2011] . Altered expression of FOXP3 has been found in various types of autoimmune diseases [Liu et al., 2013] and tumors [Cunha et al., 2012; Martin et al., 2010; Szylberg et al., 2016] . Genetic mutations in FOXP3 result in autoimmunity and inflammatory syndromes, both in humans and in mice [Fontenot et al., 2003; Khattri et al., 2003; Mayer et al., 2014; Mercer and Unutmaz, 2009 ]. Most of the experimental evidence indicates that FOXP3 deficiency is responsible for IPEX (immunodysregulation polyendocrinopathy enteropathy X-linked) syndrome which is a rare disease caused by dysfunction of Tregs [Bennett et al., 2001] .
Target genes of FOXP3 have been identified through intensive studies [Marson et al., 2007; . Meanwhile, progress in high-throughput technical developments, such as ChIP-seq and ChIP-Chip, have started to illuminate genetic and epigenetic mechanisms regulating expression or protein stability of FOXP3 [Chen et al., 2013; Floess et al., 2007; Fu et al., 2012; Gao et al., 2015; Miyara and Sakaguchi, 2007; Schmidt et al., 2012] . The majority of known upstream regulators of the expression of FOXP3 are general regulatory genes, e.g. those controlling interleukin signaling pathways (IL2, IL4, IL6 and so on) and cell surface receptors (TGFB) [Lal and Bromberg, 2009] . Those genes tend to regulate a large number of genes far beyond FOXP3, which might cause significant unwanted side effects when being targeted.
More specific upstream genes regulating FOXP3 are still largely unknown. Identifying these regulators of FOXP3 may be crucial for developing new immunotherapeutics against autoimmune and other related diseases. Unbiased experimental screening of the whole genome for such upstream regulators is almost impossible with current experimental approaches. However, such tasks can be efficiently performed computationally. This is the goal of this work.
The models trained in this work are based on microarray data of the whole-genome mRNA expression in isolated human Tregs [He et al., 2012] . Tregs from two different donors were stimulated at time zero with anti-CD3/-CD28/IL2, and measurements were taken at time zero followed by sampling every twenty minutes over a period of six hours (19 time points in total). After the pre-processing of the data, as outlined in column 1 of Fig. 1a and described in Supplementary Section 1.1, there were 13601 transcripts left, corresponding to 7826 genes. A gene can correspond to multiple transcripts, each measured by a separate probe set; from now on for simplicity we will only use the term transcripts and omit the term probe set. The role of the computational modelling was to reduce this number to 5 genes, reflecting our available experimental resources for validation.
Existing models capture known regulations of genes by FOXP3 [Carbo et al., 2013 [Carbo et al., , 2015 Hong et al., 2011; van den Ham and de Boer, 2008] , so they were not useful in finding novel regulators of FOXP3. Hence, we need to fit new models from data that capture causality, i.e. that identify those genes that cause changes in FOXP3. Here, we take advantage of a relatively large number of available time-series Tregs samples to fit dynamical models. In particular, ordinary differential equations are mathematical abstractions that capture both dynamics and causality, and help build testable hypotheses in experiments. Our models take as inputs the time-series expression values of the whole genome, i.e. each of the 13601 transcripts left after pre-processing of the data, and FOXP3 as the single output (target).
There is always a trade-off on the choice of model complexity. With rich data, models can be complex, providing detailed information of mechanisms of action. However, with limited data, complex models can easily overfit and introduce bias, resulting in large numbers of false negatives. In our case, with only a single time-series experiment and limited resources for validation, we consider the simplest dynamical model: first-order linear time-invariant (LTI) systems, a well established modelling strategy [Dalchau, 2012; Herrero et al., 2012; Mombaerts et al., 2019b Mombaerts et al., , 2016 Müller et al., 2019] . Moreover, to scale the method to the whole genome, we built a large number of simple pairwise models (one per transcript), testing whether each transcript on its own could regulate FOXP3. A model associated with a particular transcript is given by
The left-hand side of the equation is the derivative of FOXP3 expression over time, i.e. the rate of change of the concentration of FOXP3. Finally, we searched for parameters a, b that best fitted the data. This procedure was repeated for all 13601 transcripts. Given the simplicity of the models, high fit means high confidence that such regulation of FOXP3 may indeed exist. This method was summarised in column 2 of Fig. 1a and further details are in Supplementary Sections 1.2 and 1.3.
Potential regulators of FOXP3 identified here may or may not be transcription factors. Indeed, our models can capture both direct or indirect regulations of FOXP3. Indirect regulations involve other molecules and typically require larger dimensional models to capture the dynamics of intermediate steps. To avoid increasing model complexity and still consider indirect regulations, we introduced a single time delay τ in the input signal
Hence, each model had a total of three parameters. Finally, transcripts were ranked according to how likely they are to regulate FOXP3. This was illustrated in column 3 of Fig. 1a and described in Supplementary Section 1.3. We decided to focus on the top 176 transcripts (Tab. S1) out of 7030. Fig. 1b showed a significant change in the rate of change of the fitness values, i.e. a kink, after approximately the first 176 transcripts (additional details are provided in Supplementary Section 1.4). Of those, there were 161 distinct genes, since 15 of the 176 transcripts corresponded to the same genes. These genes covered fitness values ranging from 62 to 46 (the higher the fitness value, the better; 100 is perfect fit). Among the remaining 161 top ranked genes, FOXP3 is known to bind the promoters of 59 genes [Sadlon et al., 2010] , and 38 genes are reported to be differentially expressed in human Tregs compared to CD4+CD25-effector T cells (Teffs) [Sadlon et al., 2010] . For 15 genes, both statements were true. As a first literature validation test, this shows that the predicted top ranked genes are indeed involved in the regulatory pathways related to FOXP3, already supporting the relevance of our prediction.
Next, we experimentally validated some of the 161 top ranked genes in primary human Tregs ( Fig. 2a , details in Supplementary Section 2). Considering the available resources, we selected only 5 genes: NCOA7, MAP1LC3B, NRBF2, PDE4D and RNF12 (Fig. 1c ). The choice of these 5 genes was mostly based on a smooth dynamical profile with rise and fall dynamics ahead of FOXP3, and a diversity of activity in different cell parts. The details of this selection are provided in Supplementary Section 1.4.
Our experimental results showed a successful knockdown of MAP1LC3B, NCOA7 and NRBF2 using siRNA specifically targeted against the corresponding gene relative to a control scrambled siRNA in primary human Tregs (Fig. 2b, c and d) . Excitingly, knockdown of MAP1LC3B, NCOA7 and NRBF2 down-regulated the transcript expression of FOXP3 in Tregs (Fig. 2b, c and d ). The dynamics of FOXP3 expression following siRNA treatment was slightly different for the three candidates. For the other two candidates, PDE4D and RNF12, although we successfully knocked down their mRNA expression, there was no clear effect on the mRNA expression of FOXP3 (data not shown here).
Next, we tested the potential effect on protein production. All our predictions were based on models built from mRNA data, not protein expression. Due to the limited availability of reliable antibodies on MAP1LC3B, we performed Western Blotting analysis to test the effects of knockdown of only NCOA7 and NRBF2 on the protein expression of FOXP3. So far, we could only successfully demonstrate the downregulation of NRBF2 protein expression. Notably, in line with the mRNA results, dowregulation of NRBF2 protein expression indeed reduced the expression of certain isoforms of the FOXP3 protein ( Fig. 2e ), possibly due to altered alternative splicing [Allan et al., 2005] . All these experiments have been successfully repeated in Tregs isolated from peripheral blood of 6 to 8 healthy donors, depending at which level (protein or mRNA or both) the validation was performed. The effect was not observed in 1 or 2 of the tested donors possibly due to the heterogeneous nature of human individual samples.
NRBF2 is known to regulate the activity of VPS34 [Lu et al., 2014] . Moreover, T-cell specific depletion of VPS34, significantly impaired the maintenance and the suppressor function of Tregs [Parekh et al., 2013] . Our results, together with these published works, already indicate that NRBF2 might be a promising upstream regulator that modulates the expression of FOXP3.
One limitation of our computational approach is that, being based on a linear dynamics, it might miss complex non-linear interactions. Furthermore, since our method checks one transcript at a time as a potential regulator of FOXP3, it might miss interactions requiring cooperativity among several regulators at a time. Due to limited amount of data available, however, higher model complexity is likely to lead to overfitting and false positives.
Since the ground truth behind the biological system that generated this data is unknown, the safest route is to consider low complexity models, as we did here. Moreover, many transcription factors are regulated at the post-transcriptional level, which are not captured by our models and predictions (since the models are built on transcriptional data alone).
In summary, we applied dynamic modelling techniques to predict upstream regulatory genes of FOXP3, the master regulator of Tregs. Then, we experimentally validated the predicted effect of a handful of genes. Silencing of any of the three genes MAP1LC3B, NCOA7 and NRBF2 down-regulated the transcript expression of FOXP3. Moreover, dowregulation of NRBF2 protein expression reduced the expression of FOXP3 protein. Although NRBF2 knockout mice do not show spontaneous autoimmune phenotypes, NRBF2 positively regulates the autophagy process [Lu et al., 2014] , which has been widely associated with autoimmune diseases [Gianchecchi et al., 2014] . Moreover, an integrative meta-analysis from around 72 million functional associations shows that NRBF2 is ranked as the sixth candidate gene related to juvenile rheumatoid arthritis [Rouillard et al., 2016] , one of the classic autoimmune diseases. Overall, our results enhance our understanding of the upstream regulatory mechanisms of FOXP3, with the potential to develop new immunotherapeutics. Our results are solely derived from human primary T cells and therefore guarantee their application potential in medicine.
Potential future developments include, but are not limited to, the following: (1) to experimentally test MAP1LC3B, NCOA7 and NRBF2 in vivo in animal models, for example using corresponding wholebody or T-cell-specific knockout mice under homeostatic and pathological conditions; (2) to experimentally investigate additional regulators of FOXP3 from the predicted list of top ranked genes; (3) to apply the same computational approach to identify regulators of CTLA4, another important gene of relevance for Tregs, and (4) Gao, Y., Tang, J., Chen, W., Li, Q., Nie, J., Lin, F., Wu, Q., Chen, Z., Gao, Z., Fan, H., Tsun, A., Shen, J., Chen, G., Liu, Z., Lou, Z., Olsen, N. J., Zheng, S. G., and Li, B. (2015) . Inflammation negatively regulates foxp3 and regulatory t-cell function via dbc1. Proceedings of the National Academy of Sciences, 112(25):E3246-E3254.
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SUPPLEMENTARY MATERIAL

COMPUTATIONAL METHODS DETAILS
Time-Series Data Normalisation and Filtering
As shown in Fig. 1 , first of all we obtained the raw data corresponding to Tregs cells from the online supplementary material of [He et al., 2012] . Therein, microarray measurements were performed for every 20 min over the period of 6 h, after stimulation by anti-CD3/CD28/human rIL2 at time 0 h on Treg cells from two donors (here referred to as donor-1, donor-2). This data contained 54676 transcripts/probe sets for each donor, mapping various transcript variants of almost each gene in the whole genome. For simplicity, we elsewhere only use the term transcript and skip the more technical term probe set, keeping in mind that they are in a one-to-one relation, thus exchangable. Before applying any system identification technique, these time-series data need to be preprocessed. This involves normalising the data using the gcrma algorithm [Wu and Irizarry, 2010] which is implemented in MATLAB. For this and all the other computational aspects of this work, MAT-LAB versions R2016a, R2016b and R2017a were used. The normalised data were then subject to filtering. Firstly, we applied affymetrix flag filter, where any transcript was removed if marked as absent in every measurement taken at each instant of time. Conversely, we kept all the transcripts for which at least one measurement taken at any instant of time was marked with marginally present or present. The second filter applied removed the transcripts for which the average intensity (of the mRNA expression, which depends on the normalisation used above) is <50, or the largest intensity among measurements performed at any time is <100 (in the arbitrary units used by the gcrma algorithm). After this filtering, 14712 transcripts were left for donor-1 and 14472 transcripts for donor-2. The intersection of these two ensembles led to a common set of 13601 transcripts left.
One-2-one Method
Here, we used the methodology presented in [Mombaerts et al., 2019b] to identify candidates regulators for FOXP3. This modeling strategy uses Linear Time-Invariant (LTI) models to capture the dynamics describing the rate of change of the selected transcript with respect to another input transcript. A linear modelling paradigm offers advantages when data are scarce. In particular, although linear models do not provide detailed functioning of the whole network, they are capable of identifying regulatory interactions with a reliable degree of precision (see below). A LTI model can be generally represented by the following set of equations:
(1)
The model investigates whether the rate of change of the gene expression of a particular transcript y(t) depends on the gene expression of another transcript u(t).
In particular, u(t) and y(t) represented the time series of the gene expression over time of a potential regulator of FOXP3 and FOXP3, respectively. The variable x(t) represented internal dynamics (translation, transcription, etc...) that interacted with the modelled output and were required for the behaviors observed, but were not explicitly included in the model. The dimension of the vector x(t) defines the model order: in general it can be a 1-dimensional vector (direct regulation or relatively slow dynamics compared to internal dynamics), or a multi-dimensional vector (the regulation happens through intermediate steps that introduce delays and cannot be ignored).
Estimating a model involves finding A, B and C which produce a vector y(t) as close as possible to the real expression data. On the one hand, complex nonlinear models have the potential to capture the dynamical relationships between genes with great precision. On the other hand, high complexity can lead to overfitting (fitting noise instead of dynamics) without sufficient data or detailed knowledge such as the network topology or types of nonlinear interactions. Here, we restricted the model order to one as it was optimally estimated in [Mombaerts et al., 2019b] . Hence, A, B and C were scalars. Furthermore, since y is the measurement of a single state, C then consists of a scalar of value 1. System identification was performed using the function 'pem' implemented in MAT-LAB to minimise the prediction error [Ljung, 2003] .
Each model was characterized by a performance index that represents the capability of the model to describe the input-output relationship. To do so, we used the fitness:
where y k represented the data (output),ȳ the average value of the data, andŷ k the estimated output. MATLAB function compare can be used to compute the fitness of the model. A fitness equal to 100% corresponds to a perfect identification. A high fitness suggests that most of the dynamics was captured.
Then, to investigate the potential regulators of FOXP3, a collection of 1st order LTI models was estimated from each of the transcripts to FOXP3. In each case, the parameters were estimated so that they together provided the best possible fit to FOXP3 time course data. This step took the following form:
where n corresponds to the amount of candidates. Each model was characterized by a fitness metric that ranges from 0% to 100%, representing its capability of describing the original regulatory system between genes. A gene, therefore, would be further considered as a regulator for FOXP3 if the model obtained using one of its transcripts was capable of reproducing the expression profile of FOXP3 with a sufficient degree of precision, which should be characterized by a high goodness of fit, as defined above.
Additionally, we derived the mathematical expression of the dynamics of FOXP3 to explicitly include a delay in the modelling, such that it took the following form:
where µ u1 is a delay chosen between 0 min and 100 min, with steps of 20 minutes. The choice µ u1 = 0 min reduces the models to the particular case employed above.
A systematic comparison of our methodology against state-of-the-art methods with data simulating similar experimental conditions can be found in [Mombaerts et al., 2019a] .
Applying the One-2-one to our data:
All-2-one approach
For the system identification we only considered the transcripts that were left after filtering, as described above. Since, the number of transcripts differed between the two donors, we collected the common transcripts between the 14712 and 14472 transcripts (last step of column 1 of Fig. 1a ). Our All-2-one algorithm used these remaining transcripts, one at a time, as an input (regulatory gene, represented by the variable u i (t) in Eq. (3)), for the system identification technique described above as One-2-one (first step of column 2 of Fig. 1a ). As output target, the two FOXP3 transcripts were used separately, one at a time. In fact, out of 3 measured transcripts of FOXP3, only two were considered here, because the third transcript associated to FOXP3 got discarded by the average intensity filter described earlier because of its very low expression. The All-2-one was repeated for each donor which gave us a total of 4 sets of All-2-one results (i.e. each input towards the two FOXP3 transcripts, for each of the two donors). The results contained fitness score of each input towards each output (second step of column 2 of Fig. 1a) and an indication whether the regulatory gene was tentatively an activator or a repressor of the target gene. Out of the 4 sets of All-2-one results, we now combined the results of 2 FOXP3 transcripts within each donor (third step of column 2 of Fig. 1a ). Then we discarded any input transcript which corresponded to two models (one in each donor) being inconsistent in showing activation or repression towards any of the FOXP3 transcripts (fourth step of column 2 of Fig. 1a ). In fact, this would reflect an inconsistency between the inferred mathematical models. This yielded 3515 transcripts of inputs in each donor. Since there were two outputs, that meant 7030 models identified left (each with an associated fitness score) in each donor.
Typically, the time passing between the expression of a regulatory gene and that of its target gene is around 20 to 60 minutes. The One-2-one method tended to attribute higher fitness to models where the output signal follows the input signal pattern with one time-point distance, which in our case corresponded to 20 minutes. Thus, in order to identify regulations occurring over times longer than 20 minutes, we needed to modify the One-2-one method by introducing time-delays in the input signals only, Eq. (4). Thus, we ran a new round of All-2-one, with delays of 0, 20, 40, 60, 80 and 100 minutes, i.e. equivalent to moving each input signal to the right by 20-100 minutes (first step of column 3 of Fig. 1a ). Here, for each input-output combination (i.e. model), only the highest fitness score among all 6 delay cases was retained (second step of column 3 of Fig. 1a ). Even though for completeness this procedure was repeated exactly the same way for each donor, for the subsequent ranking we only utilised the results of donor-2, because in this donor FOXP3 mRNA expression showed a dynamics much more robust against noise. Eventually, these fitness scores were used to rank the 7030 models of donor-2 in a descending order (last step of column 3 of Fig. 1 , see Tab. S1 in Supplementary Material for the high ranking part of the list of genes). This ranking was the main result of our computational method and higher the ranking of a gene, the more likely it is to be involved in FOXP3 regulation.
Selection of Genes for Wet-Lab Experiments
The above mentioned results corresponded to hypothesizing several regulations, in particular the higher the ranking of a gene, the more likely it is to be involved in FOXP3 regulation. Genes which received a high fitness score, and thus were ranked in high positions in our list, were predicted to be potential regulators of FOXP3. Any threshold separating high and low ranked genes would be somewhat arbitrary. However, plotting the fitness score against the model number (Fig.  1b) , we remarked that two regimes can be identified, separated by a "knee" occurring after the first few hundred models. The first regime corresponded to higher fitness values, and the fitness value decreased steeply with model number. The second regime corresponded to lower fitness values, and it decreased almost linearly with the model number, until a final kink where fitness went to zero.
The upper part of the fitness scores, before the knee, corresponded to fitness values ranging from 62.14 to 45.78. These high fitness models included 176 models, which corresponded to approximately 2.5% of all models. We considered only these models as having a fitness high enough to represent a potential regulator of FOXP3 worth investigating further. The list of these 176 transcripts is reported in the Supplementary Material as Tab. S1. These 176 transcripts corresponded to 161 genes, since in 15 cases two transcripts corresponded to the same gene.
However, testing all of these 161 genes in vitro is practically impossible, due to the intrinsic limitations of available resources, and in practice we could test only five of these regulations in vitro. We thus needed to select five such promising regulatory genes for further laboratory experimental validation. Since the fitness scores of these genes were very close, we needed to choose which one to test based on other criteria, knowing that any criterion to select potential regulators will be somewhat arbitrary, but with the goal of selecting genes that were both likely to be regulators of FOXP3, and of potential biological relevance.
We thus performed this selection of five genes potentially regulating FOXP3 to be tested in vitro by means of the following considerations. First, transcripts were excluded when corresponding to more than one Entrez gene ID (more than one gene name due to the shared transcripts among genes) based on the HG-U133 plus 2.0 array annotation file (http://www.affymetrix.com /, version 24, 7 March 2008 [He et al., 2012 ). Further, as already mentioned, the data of donor-2 were of higher quality (less affected by noise) w.r.t. those of donor-1, thus we only considered the data for donor-2 for selection purposes. Next, we required a reasonably clean dynamics of the time series signals, and a reasonable visually assessed dynamic behaviour. Furthermore, as mentioned we introduced a time-delay, and retained for each transcript only the model corresponding to the time-delay providing the highest fitness for each transcript. We also considered this delay information while performing our selection. We observed the time-difference between the peak of the candidate regulatory transcript and the peak of FOXP3 transcripts of donor-2. The reason behind this was that usually between the peak in mRNA production for a regulating transcript, and the peak of mRNA production of the regulated transcript, there usually need to be a certain amount of time which we considered to be reasonably between about 20 to 60 minutes to translate the mRNA of the first transcript into protein, which needs the time to bind to the promoter of the target transcript (FOXP3) and regulate its expression.
Having in these ways lowered down the 161 genes to a pull of 20, we performed a final selection on the basis of biological significance (gene ontology, based on http://amigo.geneontology.org/amigo, and protein location inside/outside the nucleus, based on https://www.uniprot.org/). On one hand, we preferred genes related to transcription and located in the nucleus, since the part of the regulatory pathways of FOXP3 which is largely unknown is predominantly the one occurring in the nucleus (see e.g. Lal and Bromberg [2009] ). On these criteria, we selected 3 genes: NRBF2, NCOA7 and RNF12. On the other hand, we also did not want to limit ourselves to these predefined hypothesized functions and locations, so for the remaining two slots we selected genes representing different functions and with proteins located outside the nucleus, namely PDE4D and MAP1LC3B.
Thus based on all the criteria above we selected 5 regulatory genes for subsequent in vitro test, namely NCOA7, NRBF2, RNF12, PDE4D and MAP1LC3B.
Software Availability
The codes developed in MATLAB which implement our computational approach and perform the described ranking of transcripts are available online at https://github.com/StefanoMagni/ ModellingRegulatorsFOXP3. Sorted Treg were cultured in IMDM (21980-032, ThermoFisher Scientific) complete medium, supplemented with 10% heat-inactivated (56 • C, 45 min) fetal bovine serum (FBS) (10500-064, Ther-moFisher Scientific), 1x Penicillin+Streptomycin (15070-063, ThermoFisher Scientific), 1x MEM nonessential amino acids (M7145, Sigma-Aldrich) and 1x β-mercaptoethanol (21985-023, ThermoFisher Scientific) at 37 • C, 7.5% CO 2 . The medium was further supplemented with 100 U/ml of recombinant human IL2 (2238131, Novartis) for the culture of Tregs. For a maximum duration of 6 weeks, the Tregs were restimulated every 7 days with irradiated Epstein Barr virus (EBV) (strain B95-8, VR-1491, ATCC) transformed B cells (EBV-B cells), at a 1:1 ratio to expand and maintain the culture. A RS2000 X-Ray Biological Irradiator was used to irradiate the EBV-B cells (Rad Source Technologies) for 30 minutes with a total of 90 Gy. On a regular basis, the Tregs were characterized by Flow Cytometry for their expression of CD4, CD25, FOXP3 and Helios and discarded if the expression of FOXP3 and/or Helios was apparently decreased.
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Flow Cytometry for Treg Characterisation 2.4 RNA Extraction
RNA was extracted using the RNeasy Mini Kit (74106, Qiagen), following the manufacturers instructions and including the digestion of genomic DNA with DNAse I (79254, Qiagen). The cells were lysed in RLT buffer (Qiagen), supplemented with 1% beta-Mercaptoethanol (63689, Sigma-Aldrich). The Nan-oDrop 2000c Spectrophotometer (Thermo Fisher Scientific) was used to measure the RNA concentration and its quality was checked by assessing the RNA integrity number (RIN) using the Agilent RNA 6000 Nano kit (5067-1511, Agilent) and the Agilent 2100 Bioanalyzer Automated Analysis System (Agilent), according to the manufacturers protocol. Only the samples with RIN of 8 or higher were considered for further analysis.
cDNA Synthesis
A maximum of 500 ng of RNA was used for human cDNA synthesis, using the Superscipt IV First Strand Synthesis System (18091050, ThermoFisher Scientific) and following the manufacturers instructions. For the first step the mastermix contained following components (per sample): 0.5 µl of 50 µM Oligo(dT)20 primers (18418020, ThermoFisher Scientific), 0.5 µl of 0.09 Uµl Random Primers (48190011, ThermoFisher Scientific), 1 µl of 10 mM dNTP mix (18427013, ThermoFisher Scientific) and RNAse free water for a final volume of 13 µl in 0.2 ml PCR Tube Strips (732-0098, Eppendorf). The reaction tubes were transferred into a C1000 Touch Thermal Cycler (Bio-Rad) or UNO96 HPL Thermal Cycler (VVR) and subjected to the following program: 5 min at 65 • C, followed by 2 min at 4 • C. For the second step, the reaction mix was supplemented with 40 U RNaseOUT Recombinant Ribonuclease Inhibitor (10777019, ThermoFisher Scientific), 200 U Super-Script IV Reverse Transcriptase (18090050, Ther-moFisher Scientific), a final concentration of 5 mM Dithiothreitol (DTT) (70726, ThermoFisher Scientific) and 1x SSIV in a total reaction volume of 20 µl. The thermocycler program for the second step was the following: 50 • C for 10 min, then 80 • C for 10 min and 4 • C until further usage. The obtained cDNA was then 5x diluted with nuclease-free water to a final volume of 100 µl. Table S2 : Key Resources. Materials employed for the experimental methods described in the text.
